SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-063533
Filing Date
2024-05-22
Accepted
2024-05-22 16:33:26
Documents
10
Effectiveness Date
2024-05-22

Document Format Files

Seq Description Document Type Size
1 S-8 vktx-form_s-8_5.22.2024.htm S-8 123100
2 EX-4.2 vktx-ex4_2.htm EX-4.2 261673
3 EX-4.3 vktx-ex4_3.htm EX-4.3 59904
4 EX-4.4 vktx-ex4_4.htm EX-4.4 49995
5 EX-4.5 vktx-ex4_5.htm EX-4.5 46806
6 EX-4.6 vktx-ex4_6.htm EX-4.6 132514
7 EX-5.1 vktx-ex5_1.htm EX-5.1 26637
8 EX-23.1 vktx-ex23_1.htm EX-23.1 4081
9 EX-FILING FEES vktx-exfiling_fees.htm EX-FILING FEES 64652
10 GRAPHIC img246856755_0.jpg GRAPHIC 11202
  Complete submission text file 0000950170-24-063533.txt   785979
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279633 | Film No.: 24973829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)